81 related articles for article (PubMed ID: 2253234)
1. Epidermal growth factor inhibits transiently the progression from G2-phase to mitosis: a receptor-mediated phenomenon in various cells.
Kinzel V; Kaszkin M; Blume A; Richards J
Cancer Res; 1990 Dec; 50(24):7932-6. PubMed ID: 2253234
[TBL] [Abstract][Full Text] [Related]
2. EGF induces cell cycle arrest of A431 human epidermoid carcinoma cells.
MacLeod CL; Luk A; Castagnola J; Cronin M; Mendelsohn J
J Cell Physiol; 1986 Apr; 127(1):175-82. PubMed ID: 3007537
[TBL] [Abstract][Full Text] [Related]
3. A proposed common mechanism by which phorbol esters and epidermal growth factor delay the progression from G2 phase to mitosis of HeLa cells through phospholipid metabolites.
Kaszkin M; Fürstenberger G; Richards J; Seidler L; Kinzel V
Cancer Res; 1991 Aug; 51(16):4328-35. PubMed ID: 1868456
[TBL] [Abstract][Full Text] [Related]
4. Proposed role of phosphatidic acid in the extracellular control of the transition from G2 phase to mitosis exerted by epidermal growth factor in A431 cells.
Kaszkin M; Richards J; Kinzel V
Cancer Res; 1992 Oct; 52(20):5627-34. PubMed ID: 1394187
[TBL] [Abstract][Full Text] [Related]
5. Role of cdc25-C phosphatase in the immediate G2 delay induced by the exogenous factors epidermal growth factor and phorbolester.
Barth H; Hoffmann I; Klein S; Kaszkin M; Richards J; Kinzel V
J Cell Physiol; 1996 Sep; 168(3):589-99. PubMed ID: 8816913
[TBL] [Abstract][Full Text] [Related]
6. Phorbol ester-induced G2 delay in HeLa cells analyzed by time lapse photography.
Kinzel V; Bonheim G; Richards J
Cancer Res; 1988 Apr; 48(7):1759-62. PubMed ID: 3349455
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of phorbol ester on epidermal growth factor receptors in estrogen receptor-positive and -negative breast cancer cell lines.
Koga M; Musgrove EA; Sutherland RL
Cancer Res; 1990 Aug; 50(16):4849-55. PubMed ID: 2379149
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor modifies cell cycle control in A431 human squamous carcinoma cells damaged by ionizing radiation.
Laderoute KR; Ausserer WA; Knapp AM; Grant TD; Sutherland RM
Cancer Res; 1994 Mar; 54(6):1407-11. PubMed ID: 8137238
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor rapidly impairs activation of p34cdc2 protein kinase in HeLa cells at the G2-M boundary.
Barth H; Kinzel V
J Cell Physiol; 1995 Jan; 162(1):44-51. PubMed ID: 7814450
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel EGF-sensitive cell cycle checkpoint.
Walker F; Zhang HH; Burgess AW
Exp Cell Res; 2007 Feb; 313(3):511-26. PubMed ID: 17157295
[TBL] [Abstract][Full Text] [Related]
11. Effects of epidermal growth factor on transferrin receptor phosphorylation and surface expression in malignant epithelial cells.
Castagnola J; MacLeod C; Sunada H; Mendelsohn J; Taetle R
J Cell Physiol; 1987 Sep; 132(3):492-500. PubMed ID: 3498729
[TBL] [Abstract][Full Text] [Related]
12. Modulation of epidermal growth factor receptor activity and related responses by the 7-deazaguanine derivative, queuine.
Langgut W; Reisser T; Kersten H; Nishimura S
Oncogene; 1993 Nov; 8(11):3141-7. PubMed ID: 8414516
[TBL] [Abstract][Full Text] [Related]
13. Cell-cycle-dependent modulation of EGF-receptor-mediated signaling.
Newberry EP; Pike LJ
Biochem Biophys Res Commun; 1995 Mar; 208(1):253-9. PubMed ID: 7887936
[TBL] [Abstract][Full Text] [Related]
14. Radiation-induced enhanced proliferation of human squamous cancer cells in vitro: a release from inhibition by epidermal growth factor.
Kavanagh BD; Lin PS; Chen P; Schmidt-Ullrich RK
Clin Cancer Res; 1995 Dec; 1(12):1557-62. PubMed ID: 9815956
[TBL] [Abstract][Full Text] [Related]
15. Ligand depletion negatively controls the mitogenic activity of epidermal growth factor.
van de Poll ML; van Rotterdam W; Gadellaa MM; Jacobs-Oomen S; van Zoelen EJ
Exp Cell Res; 2005 Apr; 304(2):630-41. PubMed ID: 15748906
[TBL] [Abstract][Full Text] [Related]
16. Regulation by ceramide of epidermal growth factor signal transduction and mitogenesis in cell lines overexpressing the growth factor receptor.
Gallardo G; Tabraue C; Quintana J; López-Blanco F; Cabrera J; Díaz R; Estévez F; Ruiz de Galarreta CM; Fanjul LF; Santana P
Cell Mol Biol (Noisy-le-grand); 2000 Nov; 46(7):1305-12. PubMed ID: 11075960
[TBL] [Abstract][Full Text] [Related]
17. Reciprocal changes in p27(Kip1) and p21(Cip1) in growth inhibition mediated by blockade or overstimulation of epidermal growth factor receptors.
Fan Z; Shang BY; Lu Y; Chou JL; Mendelsohn J
Clin Cancer Res; 1997 Nov; 3(11):1943-8. PubMed ID: 9815583
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor (EGF) induces apoptosis in a transfected cell line expressing EGF receptor on its membrane.
Zhao X; Dai W; Zhu H; Zhang Y; Cao L; Ye Q; Lei P; Shen G
Cell Biol Int; 2006 Aug; 30(8):653-8. PubMed ID: 16750403
[TBL] [Abstract][Full Text] [Related]
19. Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies.
Masui H; Kawamoto T; Sato JD; Wolf B; Sato G; Mendelsohn J
Cancer Res; 1984 Mar; 44(3):1002-7. PubMed ID: 6318979
[TBL] [Abstract][Full Text] [Related]
20. Mitogenic response to epidermal growth factor: relationship to number, affinity, and down-regulation of EGF receptors in three murine embryo cell lines.
Aharonov A; Passovoy DS; Herschman HR
J Supramol Struct; 1978; 9(1):41-5. PubMed ID: 310496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
